@jokesten.bsky.social
Fiona Fox and Temilola Adeniyi presenting Common Ambition Bristol at #UKSBM25 @arc-west.bsky.social
March 26, 2025 at 10:37 AM
Fiona Fox and Temilola Adeniyi presenting Common Ambition Bristol at #UKSBM25 @arc-west.bsky.social
"It really can take 17 years to move evidence into practice" Mindblowing facts in keynote from Prof @felixnaughton.bsky.social #uksbm25
March 26, 2025 at 9:41 AM
"It really can take 17 years to move evidence into practice" Mindblowing facts in keynote from Prof @felixnaughton.bsky.social #uksbm25
Reposted
📢 New preprint. Our study develops the PATH-GP intervention to increase #HIV testing & #PrEP access in general practice.
Study led by @sarahdenford.bsky.social @jokesten.bsky.social
Read the full article here: www.medrxiv.org/content/10.1...
🛟 #HIVsky #GUMsky #STIsky
Study led by @sarahdenford.bsky.social @jokesten.bsky.social
Read the full article here: www.medrxiv.org/content/10.1...
🛟 #HIVsky #GUMsky #STIsky
Developing the PATH-GP (Prevention and Testing for HIV in General Practice) intervention: a Person-Based Approach intervention development study to increase HIV testing and PrEP access.
Background Testing for HIV, linkage to treatment and access to pre-exposure prophylaxis (PrEP) (medication which reduces the risk of acquiring HIV) is essential for early HIV diagnosis, treatment, and...
www.medrxiv.org
March 6, 2025 at 1:01 PM
📢 New preprint. Our study develops the PATH-GP intervention to increase #HIV testing & #PrEP access in general practice.
Study led by @sarahdenford.bsky.social @jokesten.bsky.social
Read the full article here: www.medrxiv.org/content/10.1...
🛟 #HIVsky #GUMsky #STIsky
Study led by @sarahdenford.bsky.social @jokesten.bsky.social
Read the full article here: www.medrxiv.org/content/10.1...
🛟 #HIVsky #GUMsky #STIsky
New paper reporting 6 co-use patterns & scope for harm reduction: (1) co-use to aid sleep or come down
(2) curated co-use
(3) morning and evening benzodiazepine doses with opioids throughout the day
(4) co-use binges
(5) co-use throughout the day
(6) benzodiazepine use throughout the day plus OAT
(2) curated co-use
(3) morning and evening benzodiazepine doses with opioids throughout the day
(4) co-use binges
(5) co-use throughout the day
(6) benzodiazepine use throughout the day plus OAT
Drug deaths are rising in the UK, especially in Scotland. Many involve a combination of benzo/z-drugs and opioids.
Our new quali paper explores co-use patterns and overdose risk.
Published in #HarmReduction Journal
Blog bit.ly/3EYDW68
Paper harmreductionjournal.biomedcentral.com/articles/10....
Our new quali paper explores co-use patterns and overdose risk.
Published in #HarmReduction Journal
Blog bit.ly/3EYDW68
Paper harmreductionjournal.biomedcentral.com/articles/10....
Understanding the lethal interactions between benzodiazepines and opioids to develop new harm reduction strategies - ARC West
A multidisciplinary project to understand why taking benzodiazepines or z-drugs and opioids together leads to so many deaths, brought together qualitative researchers with other specialists. One paper...
bit.ly
February 28, 2025 at 9:18 AM
New paper reporting 6 co-use patterns & scope for harm reduction: (1) co-use to aid sleep or come down
(2) curated co-use
(3) morning and evening benzodiazepine doses with opioids throughout the day
(4) co-use binges
(5) co-use throughout the day
(6) benzodiazepine use throughout the day plus OAT
(2) curated co-use
(3) morning and evening benzodiazepine doses with opioids throughout the day
(4) co-use binges
(5) co-use throughout the day
(6) benzodiazepine use throughout the day plus OAT